RNA-targeted therapies

1 paper1 finding

Outcomes

1

Lipoprotein

downin humans1

1 study

RNA-targeted therapies decrease lipoprotein in humans (80-95% or more).
Reviewphase 2 randomized trials
Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications
Journal of cardiovascular pharmacology9 Oct 2026

More on Lipoprotein

Latest

1 in 12 months

Journal of Cardiovascular PharmacologyYesterday

Targeting Lipoprotein(a) in Cardiovascular Disease: Emerging Therapies and Clinical Implications

ReviewAtherosclerotic cardiovascular disease